Gal alpha(1-3) core 6-Fucosylated N-Glycan 2AB (500pmol/vial)>98.0%(HPLC)1vial

Potassium trifluoro(naphthalen-2-yl)borate, 98%, 10g

2-Chloro-N-(1,2,3,4-tetrahydronaphthalen-1-yl)acetamide, 97%, 100mg

2-Chloro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-6-(trifluoromethyl)pyridine, 97%, 250mg

2,4-Dibromo-3-nitropyridine, 95.0%, 1g

ethyl 8-(4-ethylphenyl)-8-oxooctanoate, 97.0%, 1g

6-Bromo-1H-pyrrolo[3,2-b]pyridine-3-carbonitrile, 95.0%, 250mg

5-Phenylhydantoin>99.0%(HPLC)(T)25g

2-ACETYL-6-BROMO-8-CYCLOPENTYL-5-METHYLPYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE, 95.0%, 250mg

4-Methylisophthalonitrile, 97%, 100mg

4-(3-methoxyphenyl)-2,3-dihydro-1H-1,5-benzodiazepine, 95.0%, 2g

1,2-Diphenylethane, 95.0%, 25g

alpha,alpha,alpha',alpha'-Tetramethyl-1,4-benzenedimethanol, 97.0%, 100g